Prevention of thromboembolism in diabetic patients; blood sugar control
Mechanism of Action
Factor Xa inhibitor + Insulin sensitizer
Strength
2.5 mg (Rivaroxaban) + 500 mg (Metformin)
Brand Name : Cedasaxa-M 2.5/500 Tablets Composition: Saxagliptin 2.5 Mg+ Metformin 500 Mg Description : CEDASAXA-M 2.5/500 Tablets combine Rivaroxaban 2.5 mg and Metformin 500 mg to provide dual benefits of anticoagulation and blood sugar control. This combination is ideal for diabetic patients at risk of thromboembolic events. Rivaroxaban prevents blood clots, while Metformin helps regulate glucose levels. Always use under medical guidance to manage risks and monitor health parameters regularly for effective and safe treatment.